Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress

Paola Massi1, Marta Valenti, Marta Solinas

  • 1Department of Pharmacology, Chemotherapy and Toxicology, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy. daniela.parolaro@uninsubria.it.

Cancers
|November 28, 2013
PubMed

Insights

Cannabinoids from Cannabis sativa show potent anti-cancer effects against aggressive glioma tumors. These compounds selectively kill tumor cells, offering a promising therapeutic avenue for brain cancer treatment.

Area of Science:

  • Neuro-oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Cannabis sativa contains active compounds called cannabinoids.
  • Gliomas are aggressive central nervous system (CNS) tumors with limited treatment options.
  • Cannabinoids exhibit antiproliferative and proapoptotic effects on various cancer cells.

Purpose of the Study:

  • To review the anti-cancer properties of cannabinoids on gliomas.
  • To discuss the potential mechanisms of action for cannabinoids against gliomas.

Main Methods:

  • Review of in vitro studies on glioma cell lines.
  • Analysis of animal experimental models using glioma xenografts.
  • Examination of signaling pathways and oxidative stress induction.

Main Results:

  • Cannabinoids significantly reduce glioma tumor growth in vitro and in vivo.
  • Cannabinoids demonstrate selectivity, targeting glioma cells while sparing non-transformed cells.
  • Potential mechanisms involve modulation of cell signaling and induction of oxidative stress.

Conclusions:

  • Cannabinoids possess significant anti-glioma properties.
  • Their complex mechanisms of action warrant further investigation for therapeutic development.
  • Cannabinoids represent a promising class of agents for glioma treatment.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K